BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23166192)

  • 41. Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?
    Tenover FC; Baron EJ; Peterson LR; Persing DH
    J Mol Diagn; 2011 Nov; 13(6):573-82. PubMed ID: 21854871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical importance of Clostridium difficile finding in hospitalized patients].
    Kocić B; Stojanović P
    Med Pregl; 2008; 61(11-12):632-7. PubMed ID: 19368285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile mixed infection and reinfection.
    Eyre DW; Walker AS; Griffiths D; Wilcox MH; Wyllie DH; Dingle KE; Crook DW; Peto TE
    J Clin Microbiol; 2012 Jan; 50(1):142-4. PubMed ID: 22075589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal methods for identifying Clostridium difficile infections.
    Gerding DN; Brazier JS
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S439-42. PubMed ID: 8324164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific detection of toxigenic strains of Clostridium difficile in stool specimens.
    Gumerlock PH; Tang YJ; Weiss JB; Silva J
    J Clin Microbiol; 1993 Mar; 31(3):507-11. PubMed ID: 8458943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.
    Wroblewski D; Hannett GE; Bopp DJ; Dumyati GK; Halse TA; Dumas NB; Musser KA
    J Clin Microbiol; 2009 Jul; 47(7):2142-8. PubMed ID: 19403775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study.
    Bomers MK; van Agtmael MA; Luik H; van Veen MC; Vandenbroucke-Grauls CM; Smulders YM
    BMJ; 2012 Dec; 345():e7396. PubMed ID: 23241268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.
    Darkoh C; Dupont HL; Kaplan HB
    J Clin Microbiol; 2011 Dec; 49(12):4219-24. PubMed ID: 21976761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stool transplants: ready for prime time?
    Weissman JS; Coyle W
    Curr Gastroenterol Rep; 2012 Aug; 14(4):313-6. PubMed ID: 22585070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.
    Kok J; Wang Q; Thomas LC; Gilbert GL
    J Clin Microbiol; 2011 Oct; 49(10):3719-21. PubMed ID: 21849697
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis of Clostridium difficile--associated disease: patient selection and test perfection.
    Gerding DN
    Am J Med; 1996 May; 100(5):485-6. PubMed ID: 8644758
    [No Abstract]   [Full Text] [Related]  

  • 53. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.
    Hink T; Burnham CA; Dubberke ER
    Anaerobe; 2013 Feb; 19():39-43. PubMed ID: 23247066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemic Clostridium difficile ribotype 027 in Chile.
    Hernández-Rocha C; Barra-Carrasco J; Pizarro-Guajardo M; Ibáñez P; Bueno SM; Sarker MR; Guzman AM; Alvarez-Lobos M; Paredes-Sabja D
    Emerg Infect Dis; 2012 Aug; 18(8):1370-2. PubMed ID: 22840230
    [No Abstract]   [Full Text] [Related]  

  • 55. Challenges in the diagnosis of Clostridium difficile infection.
    Corsello PM; Micic D; Rao K; Waljee AK
    Gastroenterology; 2014 Jun; 146(7):1820-2. PubMed ID: 24768590
    [No Abstract]   [Full Text] [Related]  

  • 56. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay.
    Aichinger E; Schleck CD; Harmsen WS; Nyre LM; Patel R
    J Clin Microbiol; 2008 Nov; 46(11):3795-7. PubMed ID: 18784320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile infection: emerging concepts and treatments.
    Mathew T; Higginbottom PA
    Curr Gastroenterol Rep; 2008 Aug; 10(4):404-8. PubMed ID: 18627654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory diagnosis of Clostridium difficile infection.
    Goldenberg SD; Cliff PR; French GL
    J Clin Microbiol; 2010 Aug; 48(8):3048-9. PubMed ID: 20668301
    [No Abstract]   [Full Text] [Related]  

  • 59. Detection of C. difficile toxin as a model assay for performing fully automated high-throughput RT-PCR on clinical stool samples.
    Eigner U; Nörz D; Reucher S; Furrer J; Sun J; Chu K; Kolb M; Hefner N; Pfefferle S; Lütgehetmann M
    J Microbiol Methods; 2020 May; 172():105882. PubMed ID: 32119956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.